On restricted mean time in favor of treatment-Reference-Cited by-同舟云学术

On restricted mean time in favor of treatment

Published:2021-10-17 Issue: Volume: Page:
ISSN:0006-341X
Container-title:Biometrics
language:en
Short-container-title:Biometrics

Author:

Mao Lu¹^ORCID

Affiliation:

1. Department of Biostatistics and Medical Informatics School of Medicine and Public Health University of Wisconsin Madison Wisconsin

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Applied Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/biom.13570

Reference38 articles.

1. Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?

2. Generalized pairwise comparisons of prioritized outcomes in the two-sample problem

3. Causal Inference on the Difference of the Restricted Mean Lifetime Between Two Groups

4. Multistate Models for the Analysis of Life History Data

5. Robust Estimation of Mean Functions and Treatment Effects for Recurrent Events Under Event-Dependent Censoring and Termination: Application to Skeletal Complications in Cancer Metastatic to Bone

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining estimand for the win ratio: Separate the true effect from censoring;Clinical Trials;2024-07-30

2. Trial Design with Win Statistics for Multiple Time-to-Event Endpoints with Hierarchy;Statistics in Biopharmaceutical Research;2024-07-15

3. The future of clinical trials—goals, ideas, and discussion;memo - Magazine of European Medical Oncology;2024-04-18

4. Use of win time for ordered composite endpoints in clinical trials;Statistics in Medicine;2024-02-28

5. Rethinking survival analysis: advancing beyond the hazard ratio?;European Heart Journal: Acute Cardiovascular Care;2024-02-08